SL Science Files FDA Drug Master File for GDT Cell-Derived Exosomes

SL Science (SLBT) said Thursday that its licensor, JY BioMed, filed a new drug master file with the US Food and Drug Administration covering exosomes derived from Gamma Delta T, or GDT, cells. The ...
The Manila Times

SL Science Highlights New FDA Drug Master File for GDT Cell-Derived Exosomes, Expanding the Regulatory Foundation of its Platform

SL Science Holding Limited ('SL Science” or the 'Company”) (NASDAQ: SLBT), a Taiwan-headquartered biomedical company specializing in innovative cellular and gene therapies, today highlighted the ...
RTTNews

SL Science Files MDF For Gamma Delta T Exosomes Showing Potential In Brain Cancers

Extracellular vesicles like exosomes hold potential for passing through the blood-brain-barrier, thus treating malignancies like glioblastomas. Peer-reviewed research has established that exosomes can ...